BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24244969)

  • 1. The link between copper and Wilson's disease.
    Purchase R
    Sci Prog; 2013; 96(Pt 3):213-23. PubMed ID: 24244969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
    Purchase R
    Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease.
    Wooton-Kee CR
    Pharmacol Ther; 2023 Nov; 251():108529. PubMed ID: 37741465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease.
    Krishnan N; Felice C; Rivera K; Pappin DJ; Tonks NK
    Genes Dev; 2018 Jul; 32(13-14):944-952. PubMed ID: 29945887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical considerations for an effective medical therapy in Wilson's disease.
    Weiss KH; Stremmel W
    Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson's disease: clinical, genetic and pharmacological findings.
    Leggio L; Addolorato G; Abenavoli L; Gasbarrini G
    Int J Immunopathol Pharmacol; 2005; 18(1):7-14. PubMed ID: 15698506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilson's Disease: A Review for the General Pediatrician.
    Capone K; Azzam RK
    Pediatr Ann; 2018 Nov; 47(11):e440-e444. PubMed ID: 30423186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wilson's disease - a case report].
    Karwowska K; Skrzypek J; Chabik G; Członkowska A; Zaborowska M; Wawrzyniak S
    Pol Merkur Lekarski; 2016 Jan; 40(235):28-31. PubMed ID: 26891433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Drug Managements of Wilson's Disease: From West to East.
    Li WJ; Chen C; You ZF; Yang RM; Wang XP
    Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson's disease patients can be decoppered.
    Walshe JM
    Lancet; 1989 Jul; 2(8656):228. PubMed ID: 2568563
    [No Abstract]   [Full Text] [Related]  

  • 16. Chelating polymeric beads as potential therapeutics for Wilson's disease.
    Mattová J; Poučková P; Kučka J; Skodová M; Vetrík M; Stěpánek P; Urbánek P; Petřík M; Nový Z; Hrubý M
    Eur J Pharm Sci; 2014 Oct; 62():1-7. PubMed ID: 24815561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.
    Weiss KH; Askari FK; Czlonkowska A; Ferenci P; Bronstein JM; Bega D; Ala A; Nicholl D; Flint S; Olsson L; Plitz T; Bjartmar C; Schilsky ML
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):869-876. PubMed ID: 28988934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
    Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of intrahepatocyte copper(I) chelators as drug candidates for Wilson's disease.
    Gateau C; Delangle P
    Ann N Y Acad Sci; 2014 May; 1315():30-6. PubMed ID: 24611802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilson's disease: clinical management and therapy.
    Brewer GJ; Askari FK
    J Hepatol; 2005; 42 Suppl(1):S13-21. PubMed ID: 15777568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.